Day-to-day, it's barely noticeable
Repeat if needed
Why They Complement Each Other The biological case for combining BPC-157 and KPV is clean
Foot Ankle Clin 12:553567 Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JH (2017) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
This aspect also assists in developing the patients ability to follow directions and increases attention span
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns